Intended Cooperation
Partnering with hospitals, diagnostic centers, and research institutions. Engaging with medical distributors and regulatory stakeholders for market entry. Exploring collaboration in biomarker research and precision medicine applications.
Products/Services
- scioAKI: A novel 4-protein biomarker panel for early detection of Acute Kidney Injury (AKI), providing results 6 to 24 hours after surgery — two days earlier than current methods.
- Contract Research Services:
High-throughput and robust proteomics solutions for biotech, pharma, and academic institutions, enabling biomarker discovery, drug response profiling, and precision medicine applications.
Sciomics GmbH is a biotechnology company specializing in precision proteomics and protein biomarker-based diagnostics.
Its proprietary scioDiscover platform enables development of disease diagnostics and therapeutic approaches for precision medicine.
- Dr. Christoph Schröder
- schroeder@sciomics.de
- 06223 9689-532
- www.sciomics.de
Arrange an appointment for an
initial consultation
Are you interested in one of our projects? Then book a consultation now. We will be happy to present the project to you.
Philip Okito
General Manager and Co-Founder
- service@traide.de
- + 4922193544511
- Hohenstaufenring 42, 50674 Köln
free of charge & without obligation